🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-12-15
Trial ID
NCT06043713
Understanding the Coloplast Intermittent Catheter Selection Study: This st...
Status
Terminated
Location
UZ Leuven
Start Date
2025-10-21
Trial ID
NCT07355803
Treatments Being Tested
This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin ...
Status
Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2023-06-12
Trial ID
NCT05633615
The study protocol is part of the European (EU) project "Knowledge for impr...
Status
Enrolling By Invitation
Location
Fundació de Recerca Clínic Barcelona - Institut d'Investigació Biomèdica August Pi I Sunyer (FRCB-IDIBAPS)
Start Date
2023-10-13
Trial ID
NCT06421402
Treatments Being Tested
This phase I trial studies the side effects of pembrolizumab in treating pa...
Status
Completed
Location
University of Alabama at Birmingham Cancer Center
Start Date
2016-04-04
Trial ID
NCT02595866
This ALCHEMIST trial studies genetic testing in screening patients with sta...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-09-26
Trial ID
NCT02194738
Treatments Being Tested
This phase I/II trial tests the side effects and best dose of abemaciclib w...
Status
Recruiting
Location
UT MD Anderson Cancer Center
Start Date
2026-03-18
Trial ID
NCT06498648
Treatments Being Tested
In advanced metastatic castration resistant prostate cancer (mCRPC) progres...
Status
Recruiting
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2024-08-01
Trial ID
NCT06216249
This phase I trial studies the side effects and best dose of ubiquitin-acti...
Status
Recruiting
Location
National Cancer Institute Developmental Therapeutics Clinic
Start Date
2025-03-24
Trial ID
NCT06223542
This phase I trial studies how well a ketogenic dietary intervention works ...
Status
Suspended
Location
Ohio State University Comprehensive Cancer Center
Start Date
2025-11-17
Trial ID
NCT06391099